Published by
@ShahidNShah
@ShahidNShah
Innovates gene therapy, vaccines using AI-driven nanoparticle design
Artificial Intelligence Pharmaceuticals, Biotechnology & Drug Discovery Technologies
IMana.bio, an AI-based drug delivery startup, revolutionizes gene therapy, RNADNA therapeutics, and vaccines.Merging machine learning and nanotechnology, they pioneer genetic medicine. Their AI-driven lipid nanoparticle design surpasses traditional barriers, optimizing formulations for nucleic acid delivery. By accelerating development time and fostering innovative collaborations, Mana.bio’s platform predicts superior tissue-targeted LNPs, reshaping possibilities in pharmaceutical industries.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 21, 2024 at 6:20am